Internal Medicine, Infectious Disease · Canton, OH
NPI
1902068059
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
128 Wertz Ave NW, Ste C
Canton, OH, 44708
Phone (614) 293-2594
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
785 services
Medicare patients, 2024
271
Average age 72
Drug cost, 2024
$1.3M
1,041 prescriptions
Company payments, 2025
$984
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert E Leininger was code 99232 (hospital e&m - subsequent), 302 times for 148 patients. In total Robert E Leininger billed 785 services in 15 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 302 | 148 | $59.61 | $18K |
| 99222 Hospital E&M - Initial | Facility | 195 | 174 | $97.75 | $19K |
| 99233 Hospital E&M - Subsequent | Facility | 109 | 69 | $89.40 | $9,745 |
| 99223 Hospital E&M - Initial | Facility | 37 | 36 | $131.43 | $4,863 |
| 99213 Office E&M - Established | Office | 36 | 28 | $59.37 | $2,137 |
| 99221 Hospital E&M - Initial | Facility | 26 | 26 | $63.07 | $1,640 |
| 99213 Office E&M - Established | Facility | 22 | 15 | $45.59 | $1,003 |
By year: 2022 $63K for 807 services; 2023 $66K for 843 services; 2024 $61K for 785 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert E Leininger prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 159 prescriptions and refills. In total Robert E Leininger wrote 1,041 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 159 | 179 | 21 | $747K |
| Vancomycin Hcl Generic | 94 | 102 | 22 | $16K |
| Doxycycline Hyclate Generic | 82 | 157 | 44 | $4,370 |
| Cefepime Hcl Generic | 61 | 61 | 16 | $20K |
| Ceftriaxone Ceftriaxone Sodium | 51 | 51 | 11 | $5,143 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 40 | 46 | 34 | $956 |
| Ciprofloxacin Hcl Generic | 36 | 48 | 19 | $374 |
| Tivicay Dolutegravir Sodium | 36 | 40 | Under 11 | $121K |
| Cephalexin Generic | 32 | 47 | 23 | $259 |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 29 | 29 | Under 11 | $4,591 |
| Meropenem Generic | 28 | 28 | Under 11 | $6,285 |
| Cefdinir Generic | 27 | 38 | 20 | $723 |
| Ertapenem Ertapenem Sodium | 25 | 25 | Under 11 | $5,799 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 24 | 24 | Under 11 | $86K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 17 | 27 | 12 | $152 |
Brand drugs: 310 claims; generic drugs: 731 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert E Leininger $984 ($984 in general payments such as food, travel and fees) from 11 companies. The largest payer was Gilead Sciences, Inc. with $328.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 11 | $328 |
| ViiV Healthcare Company GSK | 11 | $168 |
| Merck Sharp & Dohme LLC MRK | 6 | $146 |
| Aimmune Therapeutics, Inc. | 9 | $143 |
| Abbvie Inc. ABBV | 3 | $48.65 |
| Insmed, Inc. INSM | 2 | $48.06 |
| Theratechnologies Inc. THTX | 1 | $28.48 |
| Astellas Pharma US Inc 4503.T | 1 | $23.09 |
| Shionogi Inc 4507.T | 1 | $18.5 |
| Cumberland Pharmaceuticals, Inc. CPIX | 1 | $17.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.